Scarica l'app Stockscreener
4.26
0.47%
0.02
Dopo l'orario di chiusura:
4.10
-0.16
-3.76%
Precedente Chiudi:
$4.24
Aprire:
$4.28
Volume 24 ore:
2.03M
Relative Volume:
0.81
Capitalizzazione di mercato:
$364.62M
Reddito:
-
Utile/perdita netta:
$-36.95M
Rapporto P/E:
-5.0714
EPS:
-0.84
Flusso di cassa netto:
$-33.46M
1 W Prestazione:
-6.37%
1M Prestazione:
+6.50%
6M Prestazione:
+131.52%
1 anno Prestazione:
-44.75%
Intervallo 1D:
$4.195
$4.53
Intervallo di 1 settimana:
$3.875
$4.54
Portata 52W:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Nome
Larimar Therapeutics Inc
Settore
Industria
Telefono
844-511-9056
Indirizzo
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Confronta LRMR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
4.26 | 333.80M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-29 | Iniziato | Truist | Buy |
| 2024-10-16 | Iniziato | Oppenheimer | Outperform |
| 2024-10-03 | Iniziato | Wedbush | Outperform |
| 2024-10-02 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-04 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-03 | Iniziato | Leerink Partners | Outperform |
| 2023-11-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-19 | Iniziato | Guggenheim | Buy |
| 2022-02-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-01 | Iniziato | William Blair | Outperform |
Mostra tutto
Larimar Therapeutics Inc Borsa (LRMR) Ultime notizie
Real time breakdown of Larimar Therapeutics Inc. stock performance2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Is Larimar Therapeutics Inc. stock poised for growthExit Point & AI Driven Price Predictions - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Investors to Reach Out - ACCESS Newswire
Larimar Therapeutics, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsLRMR - MarketScreener
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Benzinga
How to track smart money flows in Larimar Therapeutics Inc.Trade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Is Larimar Therapeutics Inc. (ZA71) stock worth buying before Fed actionMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Multi factor analysis applied to Larimar Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Larimar Therapeutics, Inc. Securities Lawsuit Investigation - Claim Depot
Larimar Therapeutics Reports Promising Clinical Data Update - TipRanks
Larimar Therapeutics, Inc. Updates on Nomlabofusp Development - TradingView
What candlestick patterns are forming on Larimar Therapeutics Inc.Earnings Trend Report & Daily Oversold Stock Bounce Ideas - newser.com
How Larimar Therapeutics Inc. (ZA71) stock compares with top peersMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Market reaction to Larimar Therapeutics Inc.’s recent newsMarket Performance Report & Free Safe Entry Trade Signal Reports - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc.LRMR - Eastern Progress
Larimar Therapeutics (NASDAQ:LRMR) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Intraday pattern recognizer results for Larimar Therapeutics Inc.2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
How to forecast Larimar Therapeutics Inc. trends using time seriesQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Lost Money on Larimar Therapeutics, Inc. (LRMR)? Possible FraudContact Levi & Korsinsky Today - Newsfile
Volatility clustering patterns for Larimar Therapeutics Inc.July 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - newser.com
What MACD and RSI say about Larimar Therapeutics Inc.Trade Ideas & Verified Stock Trade Ideas - newser.com
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Larimar announces 25 mg, 50 mg data from OL study of nomlabofusp - MSN
Citizens JMP Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛
Why Larimar Therapeutics Inc. (ZA71) stock fits value portfoliosDip Buying & Short-Term Trading Alerts - newser.com
Using Python tools to backtest Larimar Therapeutics Inc. strategiesJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - newser.com
Can you recover from losses in Larimar Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Larimar Reports Positive Long-Term Data on Nomlabofusp in Friedreich’s Ataxia - MyChesCo
What’s next for Larimar Therapeutics Inc. stock priceEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
What analysts say about Larimar Therapeutics Inc stockDouble Top/Bottom Patterns & Low Risk Trading Portfolio - earlytimes.in
Will Positive Nomlabofusp Study Results Alter Larimar Therapeutics' (LRMR) Standing in Rare Disease Treatment? - Yahoo Finance
Why Larimar Therapeutics (LRMR) Is Up After Positive Long-Term Results for Friedreich's Ataxia Therapy - Sahm
Larimar Therapeutics (NASDAQ:LRMR) Price Target Cut to $21.00 by Analysts at Oppenheimer - Defense World
Why ETFs are accumulating Larimar Therapeutics Inc. (ZA71) stockDividend Hike & Real-Time Stock Movement Alerts - newser.com
Oppenheimer Maintains Larimar Therapeutics (LRMR) Outperform Recommendation - Nasdaq
Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Oppenheimer Lowers Larimar Therapeutics (LRMR) Price Target to $21 | LRMR Stock News - GuruFocus
Equities Analysts Issue Forecasts for LRMR FY2027 Earnings - MarketBeat
Is now a turning point for Larimar Therapeutics Inc.2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):